Company: RNGE
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001641172-25-001343
Chunk: 727

Company: RANGE IMPACT, INC.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 7A
Chunk 727
---
4.

(4)
Mr. McKilligan moved to serve as CFO of Graphium Biosciences effective April 25, 2024 and remained with that entity until it was spun
off in September 2024.

(5)
Dr. Zipp moved to serve as Chief Science Officer of Graphium Biosciences effective April 25, 2024 and remained with that entity until
it was spun off in September 2024.

35

Outstanding
Equity Awards at December 31, 2024

    Option
    Awards

    Number
    of securities underlying unexercised option  
    Option
    Exercise  
    Option Expiration

    Grant
    Date 
    Exercisable  
    Unexercisable  
    Price
    ($)  
    Date
  
    Michael Cavanaugh (1) 
    5/8/2019 
     500,000  
     -  
     0.35  
    5/8/2029

    6/27/2019 
     250,000  
     -  
     0.30  
    6/27/2029

    12/10/2021 
     350,000  
     -  
     0.277  
    12/10/2031

    11/30/2022 
     750,000  
        
     0.18  
    11/30/2032

    12/21/2023 
     1,000,000  
        
     0.212  
    12/21/2033

    Patricia Missal (2) 
    4/25/2024 
     125,000  
     125,000  
     0.38  
    4/25/2034

    Richard McKilligan (3) 
    7/18/2016 
     370,234  
     -  
     0.50  
    7/18/2026

    6/27/2019 
     250,000  
     -  
     0.30  
    6/27/2029

    12/10/2021 
     150,000  
     -